// App-Quantinova.ai

e52 : Characteristics of patients treated with biologic monotherapy and combination therapy for moderate or severe rheumatoid arthritis in five European countries

Researchers

Presenter

  • Emma Sullivan

Principal Investigators

  • Jim Kershaw

  • Stuart Blackburn

  • Puneet Mahajan

  • Susan Boklage

Medical Centers

  • AutoImmune, Adelphi Real World, Bollington, UNITED KINGDOM

  • Health Economics and Value Assessment, Sanofi, Bridgewater, NJ, USA

  • Health Economics and Outcomes Research, Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved